The FDA has granted Reflow Medical breakthrough device designation for its Temporary Spur Stent system for use in below-the-knee peripheral artery disease treatment. The company eyes continued development of the device in other clinical areas and plans to expand on clinical evidence for the system.
FDA grants breakthrough status to Reflow's PAD treatment system
Sign up for AdvaMed SmartBrief
Medical technology news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.